Zeerleder S - Search Results

1

C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia.

Wouters D, Stephan F, Strengers P, de Haas M, Brouwer C, Hagenbeek A, van Oers MH, Zeerleder S. Wouters D, et al. Among authors: zeerleder s. Blood. 2013 Feb 14;121(7):1242-4. doi: 10.1182/blood-2012-11-467209. Blood. 2013. PMID: 23411737 Free article. No abstract available.

2

C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor.

Wouters D, Wagenaar-Bos I, van Ham M, Zeerleder S. Wouters D, et al. Among authors: zeerleder s. Expert Opin Biol Ther. 2008 Aug;8(8):1225-40. doi: 10.1517/14712598.8.8.1225. Expert Opin Biol Ther. 2008. PMID: 18613773 Review.

3

C1-esterase inhibitor protects against early vein graft remodeling under arterial blood pressure.

Krijnen PA, Kupreishvili K, de Vries MR, Schepers A, Stooker W, Vonk AB, Eijsman L, Van Hinsbergh VW, Zeerleder S, Wouters D, van Ham M, Quax PH, Niessen HW. Krijnen PA, et al. Among authors: zeerleder s. Atherosclerosis. 2012 Jan;220(1):86-92. doi: 10.1016/j.atherosclerosis.2011.10.021. Epub 2011 Oct 25. Atherosclerosis. 2012. PMID: 22078245 Free article.

4

FSAP, a new player in inflammation?

Stephan F, Aarden LA, Zeerleder S. Stephan F, et al. Among authors: zeerleder s. Hamostaseologie. 2012;32(1):51-5. doi: 10.5482/ha-1187. Hamostaseologie. 2012. PMID: 22252569 Review.

5

Prolonged C1 inhibitor administration improves local healing of burn wounds and reduces myocardial inflammation in a rat burn wound model.

Begieneman MP, Kubat B, Ulrich MM, Hahn NE, Stumpf-Stolker Y, Tempelaars M, Middelkoop E, Zeerleder S, Wouters D, van Ham MS, Niessen HW, Krijnen PA. Begieneman MP, et al. Among authors: zeerleder s. J Burn Care Res. 2012 Jul-Aug;33(4):544-51. doi: 10.1097/BCR.0b013e31823bc2fc. J Burn Care Res. 2012. PMID: 22447201

6

Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease.

Stephan F, Dienava-Verdoold I, Bulder I, Wouters D, Mast AE, Te Velthuis H, Aarden LA, Zeerleder S. Stephan F, et al. Among authors: zeerleder s. J Thromb Haemost. 2012 Jun;10(6):1165-71. doi: 10.1111/j.1538-7836.2012.04712.x. J Thromb Haemost. 2012. PMID: 22449009 Free PMC article.

7

Aleukemic variant of mast cell leukemia.

Zeerleder S, van Oers M. Zeerleder S, et al. Blood. 2012 Mar 1;119(9):1961. doi: 10.1182/blood-2011-04-344952. Blood. 2012. PMID: 22482127 Free article. No abstract available.

8

Evaluating the efficacy of subcutaneous C1-esterase inhibitor administration for use in rat models of inflammatory diseases.

Emmens RW, Naaijkens BA, Roem D, Kramer K, Wouters D, Zeerleder S, van Ham MS, Niessen HW, Krijnen PA. Emmens RW, et al. Among authors: zeerleder s. Drug Deliv. 2014 Jun;21(4):302-6. doi: 10.3109/10717544.2013.853211. Epub 2013 Nov 12. Drug Deliv. 2014. PMID: 24215253

9

The effect of C1-inhibitor in a murine model of transfusion-related acute lung injury.

Müller MC, Stroo I, Wouters D, Zeerleder SS, Roelofs JJ, Boon L, Vroom MB, Juffermans NP. Müller MC, et al. Among authors: zeerleder ss. Vox Sang. 2014 Jul;107(1):71-5. doi: 10.1111/vox.12128. Epub 2013 Dec 27. Vox Sang. 2014. PMID: 24372323

10

Methods for quantitative detection of antibody-induced complement activation on red blood cells.

Meulenbroek EM, Wouters D, Zeerleder S. Meulenbroek EM, et al. Among authors: zeerleder s. J Vis Exp. 2014 Jan 29;(83):e51161. doi: 10.3791/51161. J Vis Exp. 2014. PMID: 24514151 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page